Sotio will have four programs in clinical trials phase

Published: 23.06.2021 Related countries:  U.S.A. U.S.A.

Four programs advancing to clinical phase trial at the same time

For the first time in history, the biotechnology company Sotio will have four programs at one point in the clinical trial phase. Mladá fronta Dnes writes about this, stating that, for example, the interleukin-15 project will be moved to the second phase. The study will begin with the antibody drug conjugates program, and in addition, the team in the United States is moving toward initiating a Phase I clinical trial with a modern CAR-T cell immunotherapeutic approach.


Text prepared by team of employees of foreign office CzechTrade Chicago